Introduction
The impact of operator volume on outcomes following interventional medical procedures is of great interest across many specialties, 1,2 including percutaneous coronary intervention (PCI). The current body of evidence describing this relationship is discrepant, with some studies reporting that higher operator volume is related to improved outcomes via reductions in in-hospital mortality or other adverse events, [3] [4] [5] [6] [7] and others reporting no such association. [8] [9] [10] [11] [12] [13] [14] [15] [16] While the exact nature and extent of the volume-outcome relationship in PCI is unclear, there remains an intuitive concern that interventional cardiologists who do more cases are likely to be better operators. Therefore, there is a consensus that operators should exceed a minimum number of procedures per year (ppy) to maintain a high standard of manual skills and sound clinical judgement in order to achieve competency. Current national and international guidelines offer recommendations on minimum operator PCI volume [17] [18] [19] that are summarized in Table 1 . These guidelines rely on data from no later than 2010, 16 and reflect the typical activity levels, patient characteristics, and operator practices at that time. In many countries, the case-mix for PCI has changed from predominantly elective to an increased proportion of acute coronary syndromes (ACSs), and this has been accompanied by a growth in PCI services to increase patient access. In addition, much of the interventional equipment, technologies, and pharmacology have evolved and therefore, existing literature regarding the association between PCI volume and outcome may no longer apply to contemporary practice. Two recent studies have examined patient outcomes in relation to volume in contemporary data, 7, 15 though data from a European perspective with a different healthcare delivery model are lacking. There are also several methodological limitations in many volume-outcome studies. 20 The existing literature almost exclusively relies on a categorized definition of annualized volume that differs greatly from study to study, for instance the high/low volume threshold has varied from as low as 11 ppy 14 or as high as 100 11 and synthesizing such results is challenging. The use of fixed calendar year volume is also problematic as, for instance, outcomes of procedures performed in January are modelled based on procedural volume up to 11 months later in December. Future volume should not be used to predict previous outcomes. In this recent (2013-2014) British cohort study, we report crude and risk-adjusted short-term PCI mortality outcomes in relation to operator volume. It is the first time that this relationship has been examined from a national perspective in Europe, and the first to use a pragmatic, non-categorized definition of operator volume. The suitability of existing international volume guidelines is assessed.
Methods

Study design
This retrospective, observational cohort study analysed procedures recorded in the BCIS PCI database in the 2-year period from 1 January 2013 to 31 December 2014 to assess whether operator volume is associated with independently reported 30-day mortality. Mixed effects multiple logistic regression modelling was used to account for operator and centre level effects and to adjust for potential confounders.
The BCIS database
The BCIS collects data on all PCI procedures in the UK. Data input on every case is mandated by UK Good Practice guidelines and is a specified responsibility of senior operators as part of their revalidation by the General Medical Council (GMC). The data collection is co-ordinated by the National Institute of Cardiovascular Outcomes Research (NICOR) via a centralized electronic database. 21 The BCIS-NICOR registry comprises 113 variables, including clinical variables, procedural parameters, and patient outcomes. Mortality tracking is undertaken by NHS Digital linkage with each patients' NHS number that provides a unique identifier for any person registered with the NHS in England and Wales. Because, it is a legal requirement for all deaths in the UK to be registered, these life status data are robust.
Volume definition
The GMC registration number of the 'consultant responsible for the procedure' was used to identify operators. This is a unique identifier of the consultant PCI operator and has been part of the BCIS registry since 2012. Our annualized volume metric, updated each month, is defined as the total number of procedures the consultant was responsible for in the previous 12 months across all NHS centres. For example, consultant volume in February 2013 is measured from February 2012 to January 2013. three out of 87 centres had missing data for over 10% of the 'consultant responsible for the procedure' field and all procedures from these centres were removed from the analysis (n = 6145 procedures, 4.1%). Missing consultant identifier rates for all remaining centres was less than 3.3% and these procedures were removed (n = 2891, 1.9%). Procedures where the consultant was in their first year in the registry were removed (7053, 4.7%) as volume could not be calculated in these cases. For further details refer to the Supplementary material online.
Cohort selection
Statistical analysis
Baseline patient and procedural characteristics were reported, stratified by volume quartiles (Q1 0-128; Q2 129-178; Q3 179-239; Q4 240-714), such that each strata contained an equal number of procedures (approximate due to ties), with the possibility that the same operator was present in multiple strata if her case volume moved across strata boundaries during the study period. These strata boundaries were reused to show baseline characteristic for elective and ACS procedures, separately. Histograms and quantiles were used to describe the distribution of average volume across operators. To investigate the association between volume and 30-day mortality in the presence of confounding and clustering effects, we used multivariable, mixed effects logistic regression modelling, using multiple imputation to account for missing values.
First, missing values were imputed using fully conditional specification multiple imputation with 20 imputed datasets created. Continuous variables were imputed using predictive mean matching and categorical variables using multinomial logistic regression. Imputation was not necessary for consultant and centre identifiers, volume metrics and mortality, as these were complete by design. A complete list of variables used in the imputation model is provided in the Supplementary material online. Information on completeness for each variable is provided in Supplementary material online, Table S1 . Effect estimates across imputed datasets were pooled using Rubin's rules. 22 The multivariable mixed effects model adjusted for age, sex, ethnicity, PCI indication, cardiogenic shock, intra-aortic balloon pump (IABP) support, cardiopulmonary support, inotropic support, ventilation, left ventricular ejection fraction, myocardial infarction (MI) history, coronary artery bypass grafting (CABG) history, high cholesterol, hypertension, diabetes status, renal status, smoking status, and centre volume (defined as the number of procedures performed by a centre in the previous 12 months and updated monthly). Covariates were included to adjust the models, not to provide information on their associations with outcomes, which has been more robustly achieved with patient-level analyses in other work. [23] [24] [25] Operator-and centre-level random effects were included, and these were not nested as operators often worked across multiple centres. The Wald-like test due to Li et al. 26 was used to provide reference P-values for model odds ratios (ORs) and associated confidence intervals (CIs). The intraclass correlation coefficient due to Wu et al. 27 was used to assess the variation in outcomes explained by operator-and centre-level clustering before and after the inclusion of fixedeffects. These values are reported in Supplementary material online.
Smoothed curves which showed the observed (unadjusted) mortality and model-adjusted mortality against volume to explore possible non-linear relationships.
The analysis was repeated in the subset of patients undergoing PCI for ACS, with ACS volume derived in an analogous way to overall volume. Both volume metrics were considered simultaneously in the same regression model, so that the model comparison test assesses the improvement in the goodness-of-fit of the model when adding both volume and ACS volume as linear effects. Subsetting was carried out after multiple imputation so that the same imputed data were used throughout. The analysis was also repeated in the subset of patients undergoing primary PCI in exactly the manner described for the ACS sub-analysis, using primary PCI volume.
Due to the size of the dataset, we focus on effect estimates and their interpretations and not on P-values. 28 Arbitrary significance thresholds are not used. Additional methodological details are provided in Supplementary material online.
Sensitivity analyses
We varied our methods in four different ways to assess the consistency of our results under alternative study designs. The first of these was to change the outcome from 30-day mortality to centre-reported in-hospital mortality (was the patient discharged alive or not) and also in-hospital major adverse cardiovascular events (MACE, defined here as MI, emergency reintervention via CABG or PCI, and mortality).
Second, operator volume was modelled dichotomously rather than continuously, with a threshold of 75 ppy (reflecting the BCIS guidelines recommending a minimum of 150 procedures every 2 years) and also 50 ppy (as per ECS/EAPCI and ACCF/AHA/SCAI guidelines).
Third, the interactive effect between operator volume and centre volume was examined. The additional predictive value of an interaction term between dichotomized operator volume (at 75 ppy) and categorized centre volume (0-300, 301-600, 601-1200, 1201þ ppy) was assessed using a Wald test. 26 Fourth, operator-modifiable factors (stent type, access site, and adjunct pharmacotherapy) were added as covariates (these were excluded in the primary analysis due to their dependence on decisions made by operators possibly relating to operator experience). A model that did not include IABP support, cardiopulmonary support, or inotropic support was also considered (these variables were included in the primary analysis as they are strong markers of haemodynamic instability and their use may be a matter of necessity rather than choice).
Software
All analyses were performed using R version 3.2.2. 29 The tidy verse data manipulation and visualization suite 30 was used throughout. Multiple imputation and model-pooling were implemented using the mice package, 31 mixed effects modelling using the lme4 package, 32 and restricted cubic splines using the rms package. 33 The analysis script is available on request from the first author.
Results
A total of 158 492 PCI procedures were recorded to the BCIS audit in England and Wales between 2013 and 2014. Following exclusions as described in Supplementary material online, Figure S1 , there were 133 970 (84.5%) procedures available for analysis. In total, there were 84 centres and 540 unique consultant GMC number identifiers in this cohort. This equates to an average of 6.4 consultants per centre, 124 procedures per operator per year and 797 procedures per centre per year. The mean age of the study cohort was 65.1 years (standard deviation 12.1), and 74.3% of procedures were in male patients. Elective PCI accounted for 34.6% of procedures. There were 6141 (4.6%) procedures from operators whose volume was under 75 ppy. Figure 1 shows the distribution of the average operator volume during the study. The median operator performed 135 ppy [interquartile range (IQR) 93-188 ppy]. There were 114 operators (21.1%) who had an average volume of less than 75 ppy, and 77 operators (14.3%) who performed less than 50 ppy on average. These operators contributed 4127 (3.1%) and 944 (0.7%) procedures, respectively. Table 2 reports patient and procedural factors overall and by volume, stratified by quartiles: Q1 0-128; Q2 129-178; Q3 179-239; Q4 240-714. The 30-day mortality rate was 2.6% though this differed significantly by volume, with mortality decreasing as volume increased, from 2.9% in the lowest volume stratum to 2.5% in the highest. Some factors relating to cardiovascular risk were typically more common when operator volume was higher, for instance previous MI (24.2% lowest volume to 29.6% highest volume), previous CABG (8.9-previous stroke (3.8-4.7%), hypertension (52.3-59.1%), and peripheral vascular disease (3.9-5.8%). However, shock and ventilation were proportionally lower when volume was higher. Radial access was more common in high volume operators (57.2-71.8%), as was left main stem intervention (3.6-7.2%) and multivessel PCI (10.4-17.8%).Tables 3 and 4 reports these factors in elective-only and ACSonly cohorts, respectively.
Variables correlated with volume
Multivariable models
The relationship between 30-day mortality and volume in 2013-2014 was explored in multivariable mixed effects logistic regression model. A scatter plot of model predicted mortality versus average operator volume is shown in Supplementary material online, Figure S2 . Figure 2 presents ORs for operator volume for all, ACSonly, and primary PCI-only cohorts, with these values tabulated in Table 5 . The full models are described in Supplementary material online, Tables S2a, S2b, and S2c. After adjustment for case-mix, there was no strong evidence of an independent linear association, with small effect sizes and high P-values. Potential non-linear relationships between volume and 30-day mortality were explored graphically by plotting observed and model-adjusted mortality against volume. Figures 3-5 demonstrate relatively stable model-adjusted mortality as volume varied.
Sensitivity analyses
The findings of the primary analyses were supported in all sensitivity analyses. Table 5 also lists ORs for in-hospital mortality and in-hospital MACE, and for operator volume dichotomized at 75 and 50 ppy. In these models, associations for operator volume were relative small and not statistically significant. The Wald test examining the value of an interaction term suggested no significant interactive effects between operator volume and centre volume (all procedures, P = 0.473; ACS, P = 0.740; primary, P = 0.629). The inclusion in the model of factors that depend on operator choice did not alter the direction or strength of association of volume with mortality (OR 1.02, 95% CI 0.96-1.08; P = 0.533). Similarly, excluding variables relating to cardiac support did not alter results (OR 1.00, 95% CI 0.94-1.06; P = 0.923). Further details of these sensitivity analyses are available in Supplementary material online, Tables S3a, S3b, S3c, S4a, S4b, S4c and S5.
We do not adjust for multiple comparisons when reporting these sensitivity analyses.
Discussion
This nationally representative study is the first to investigate the relationship between operator volume and outcomes within the contemporary PCI era in Europe, where revascularization following ACS is the most common indication for intervention and transradial access is the default for the majority of countries within Europe. It is the only study, where volume is not calculated based on future operator activity and does not rely solely on a contrived dichotomization or categorization of this metric.
Our analysis found no relationship between 30-day mortality following PCI and the number of cases performed by a PCI operator. Despite an inverse association between volume and mortality using crude, unadjusted data, we found that after adjusting for patient-level risk factors we can rule out any meaningful change in the odds of 30-day mortality as volume increases. This was observed both when operator volume was modelled continuously, and when volume was dichotomized at 50 or 75 ppy in line with international guidelines. Similar results were obtained in analyses of ACS only and primary PCI only procedures, and of centre-reported in-hospital mortality and in-hospital MACE.
Procedures performed by lower volume operators were on average performed to treat patients at higher baseline risk. This is consistent with the finding that there are proportionally more ACSindicated procedures when volume is low than when volume is high. Conversely, baseline cardiovascular risk typically increased with volume, a pattern that broadly persisted when looking at elective and ACS procedures, separately.
The existing literature investigating the relationship of operator volume on outcomes following PCI reports discrepant findings, with some studies reporting increases in adverse events with lower operator volume after risk-adjustment, [3] [4] [5] [6] [7] and others finding no such procedures identified from the National Inpatient Sample (NIS) database between 2005 and 2009 that showed lower in-hospital mortality in higher volume quartiles compared with the lowest quartile (1-15 ppy), with the highest volume quartile (>100 ppy) associated with the most significant reduction (OR 0.65, 95% CI 0.58-0.73; P < 0.001). However, as these studies stem from procedures performed no later than 2010, their relevance in informing contemporary best practice is diminished and should be interpreted with this in mind. In particular, this period has seen a rapid transition from trans-femoral to transradial access in the UK, with radial procedures rising from 16% in 2005 to over 75% in 2014. 35 The benefits of radial access has been demonstrated in randomized controlled trials, 36, 37 and as the strength of this benefit is positively associated with operator volume, 25 15 reported no significant differences in in-hospital mortality or a composite of peri-procedural complications outcome between operator volume deciles. Despite drawing data from a similar era and comparable radial access rates (61.3% in Japan vs. 67.5% in our study), geo-cultural disparities and average volume levels make translating these findings to Europe difficult. Our study adds a European perspective, reflecting a recent PCI era and showing that increasing volume is not associated with better mortality outcomes, and also that the majority of operators have caseloads exceeding previously defined volume thresholds. Median annualized volume in our study was 135 ppy (IQR 93-188). This is markedly higher than that found in the NIS database in the USA 6 The 150 minimum operator volume over 2 years recommended by BCIS and EAPCI 17, 38 was met or exceeded in 95.4% of analysed procedures, as measured using volume (i.e. exceeding 75 ppy). A sensitivity analysis found no difference in 30-day mortality above or below this threshold after risk adjustment. The ACCF/AHA/SCAI guidelines stipulating a minimum of 50 ppy were not met in just 1.4% of cases, making a well-powered and balanced analysis of this particular recommendation challenging.
There are fewer studies of operator volume and outcome for primary PCI. Two studies 4, 12 investigating this relationship directly found post-adjustment in-hospital mortality reductions for operators performing over 11 primary procedures annually (relative risk high vs. low 0.43, 95% CI 0.21-0.83) or over 10 primary procedures annually (OR 0.66, 95% CI 0.48-0.92). A small (N = 331) single-centre, three-operator study was also conducted 39 but with only one operator in each volume 'group', it is impossible to consider the effect of volume independent of other operator factors. Finally in the CathPCI study, the relationship between operator volume and in-hospital mortality was significant in patients presenting with STEMI with similar findings in the PPCI cohort (OR 1.03; 95% CI 1.02-1.04). The findings of these studies are not supported by our data, which suggest mortality following primary PCI is not associated with either total volume or primary specific volume, though there was considerable uncertainty around the central estimates. The need to achieve adequate geographical coverage to ensure timely access to primary PCI services, meet minimum centre activity standards, and accommodate a changing population means that future services are likely to continue to see a period of transition, affecting both centre and operator volumes. Volume-related outcome patterns in the primary PCI setting should therefore continue to be closely monitored.
Centre volume was not the focus of this study, but it was included as a potential confounder in the regression models. The latest European Heart Journal STEMI guidelines recommend that STEMI patients should be transferred to 24/7 high-volume PCI centres because of reduced mortality irrespective of the chosen treatment strategy. 40 A recent study using the BCIS registry from 2007 to 2013 41 found no change in 30-day mortality as centre volume varied.
Limitations
Investigations into volume-outcome relationships are hindered by the fact that volume cannot be independently randomized. This restricts the body of statistical evidence to non-randomized volume exposures, where the influence of confounding factors must always be carefully considered and controlled for where possible.
Our volume metric measures the number of procedures as the responsible consultant, but it was necessary to exclude cases where consultant identifier was not known or where volume, mortality, or other key variables were unavailable, though this study was still able to retain 84.5% of all available procedures, which compares favourably with other recent registry-based volume studies, for example with 54.5% 6 and 73.8% 15 in the NIS database and the J-PCI registry, respectively. We note that although consultant identifier is not likely to be missing at random, missing values were present in high and lowvolume centres similarly, and the use of random effects mitigates the potential bias induced by these exclusions.
Where volume is very low or zero, it is unclear whether this is because the operator was inactive (for example due to maternity leave), was working outside the UK, had not yet been appointed to consultant grade, or whether an uncommon or incorrect operator alias was used. Furthermore, only three operators had volume recorded greater than 500 ppy, with just one exceeding 700 ppy, and so the volume-mortality relationship in this range cannot be adequately disassociated from the relationship of mortality with individual operators. The relationship between volume and mortality in very low volume or very high volume cases should be interpreted with caution. In particular, the potential association of mortality and volume below recommended operator minimums cannot be addressed by our analysis, although we do not observe any signals towards compromised outcomes in operators performing below national/international recommendations. Centres and operators were anonymized, and additional variables at these levels, for example operator age, years since qualification, or total career PCI volume could not be accounted for. We considered in-hospital mortality and MACE as secondary outcomes, although this information cannot be independently validated and is therefore less robust than 30-day mortality. We cannot rule out that other clinical end-points may be independently associated with operator volume.
Finally, we were unable to consider whether total career volume may influence the relationships that we report, as operator identifiable information (the GMC number) was only available since 2012.
Conclusion
In our 2-year study in PCI procedures in England and Wales, we find no direct relationship between 30-day mortality and operator volume after adjusting for patient characteristics. This finding holds when looking at ACS and primary procedures, separately. A vast majority of operators had caseloads exceeding the yearly minimum recommended by BCIS, EAPCI, and ACCF/AHA/SCAI. Operator volume and mortality in PCI
